AARTI PHARMALABS
Back to Income Statement
|
AARTI PHARMALABS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,115 Cr | ₹1,853 Cr | ₹1,945 Cr | ₹1,200 Cr | - |
What is the latest Revenue of AARTI PHARMALABS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,115 Cr |
| Mar2025 | ₹1,853 Cr |
| Mar2024 | ₹1,945 Cr |
| Mar2023 | ₹1,200 Cr |
| Mar2022 | - |
How is Revenue of AARTI PHARMALABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,115 Cr | 14.17 | |
| Mar2025 | ₹1,853 Cr | -4.76 | |
| Mar2024 | ₹1,945 Cr | 62.11 | |
| Mar2023 | ₹1,200 Cr | 0 | |
| Mar2022 | - | - | |
Compare Revenue of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,924.0 Cr | 6.2% | -10.2% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 6.2% |
-10.2% |
11.5% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses